Old Web
English
Sign In
Acemap
>
authorDetail
>
Curtis Kellett
Curtis Kellett
Oncology
Medicine
Internal medicine
Performance status
Pancreatic cancer
3
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Off-label infusion of biosimilar bevacizumab: A provincial experience.
2020
Journal of Oncology Pharmacy Practice
Marc Geirnaert
Jacy Howarth
Curtis Kellett
Kristen Martin
Scott Streilein
Chad Ricard
Danica Wasney
Saroj Niraula
Show All
Source
Cite
Save
Citations (0)
Efficacy and Tolerability of Second-line Nab-paclitaxel and Gemcitabine After Failure of First-line FOLFIRINOX for Advanced Pancreas Cancer: A Single-institution Experience
2018
Clinical Colorectal Cancer
Hanbo Zhang
Curtis Kellett
Pascal Lambert
Christina A. Kim
Show All
Source
Cite
Save
Citations (7)
Efficacy and tolerability of second-line nab-paclitaxel and gemcitabine (NG) after failing first-line FOLFIRINOX in patients (pts) with advanced pancreatic cancer (APC): A single-institution experience.
2017
Journal of Clinical Oncology
Hanbo Zhang
Curtis Kellett
Pascal Lambert
Christina Kim
Show All
Source
Cite
Save
Citations (0)
1